Off‐Label Medicine Use in Pediatric Anesthesia—Recommendations of the World Federation of Societies of Anaesthesiologists (WFSA) Paediatric Committee

BACKGROUND: Off-label medicine use is the administration of a medication in any manner that is not included in the approved package insert for that medication. The off label use of medicines is common in pediatric anesthesia due to the limited number of drugs that are specifically approved for use in children. This is due to the lack of clinical drug trials involving children, resulting in the absence of safety and efficacy data for this population of patients. This may lead to an increased risk of adverse events when these medicines are used in pediatric patients and expose anesthesia practitioners to the risk of litigation. AIMS: This paper describes an approach and principles for decision making for anesthesia practitioners around use of medicines in pediatric patients undergoing anesthesia. CONCLUSION: The decision to use a medication off label should be rational, clinically appropriate and based on a balance of benefit versus risk.

Authors

Institutions

Publication Details

Journal
Pediatric Anesthesia
Published
2026-05-21
DOI
https://doi.org/10.1002/pan.70226
Primary Topic
Pharmaceutical studies and practices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Off‐Label Medicine Use in Pediatric Anesthesia—Recommendations of the World Federation of Societies of Anaesthesiologists (WFSA) Paediatric Committee

Clover-Ann Lee, Philippa Lane
Pediatric Anesthesia
Pharmaceutical studies and practices
article

Off‐Label Medicine Use in Pediatric Anesthesia—Recommendations of the World Federation of Societies of Anaesthesiologists (WFSA) Paediatric Committee

Clover-Ann Lee, Philippa Lane
article en

Abstract

BACKGROUND: Off-label medicine use is the administration of a medication in any manner that is not included in the approved package insert for that medication. The off label use of medicines is common in pediatric anesthesia due to the limited number of drugs that are specifically approved for use in children. This is due to the lack of clinical drug trials involving children, resulting in the absence of safety and efficacy data for this population of patients. This may lead to an increased risk of adverse events when these medicines are used in pediatric patients and expose anesthesia practitioners to the risk of litigation. AIMS: This paper describes an approach and principles for decision making for anesthesia practitioners around use of medicines in pediatric patients undergoing anesthesia. CONCLUSION: The decision to use a medication off label should be rational, clinically appropriate and based on a balance of benefit versus risk.

Pediatric Anesthesia
Women's and Children's Hospital (AU), Nelson Mandela Academic Hospital (ZA)
Peace, Justice and strong institutions
Openalex Percentile: Top 5%
Pharmaceutical studies and practices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.